These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

506 related articles for article (PubMed ID: 31002893)

  • 1. GLP-1: Molecular mechanisms and outcomes of a complex signaling system.
    Smith NK; Hackett TA; Galli A; Flynn CR
    Neurochem Int; 2019 Sep; 128():94-105. PubMed ID: 31002893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapies for inter-relating diabetes and obesity - GLP-1 and obesity.
    Iepsen EW; Torekov SS; Holst JJ
    Expert Opin Pharmacother; 2014 Dec; 15(17):2487-500. PubMed ID: 25260877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine signaling in the amygdala, increased by food ingestion and GLP-1, regulates feeding behavior.
    Anderberg RH; Anefors C; Bergquist F; Nissbrandt H; Skibicka KP
    Physiol Behav; 2014 Sep; 136():135-44. PubMed ID: 24560840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetes and obesity treatment based on dual incretin receptor activation: 'twincretins'.
    Skow MA; Bergmann NC; Knop FK
    Diabetes Obes Metab; 2016 Sep; 18(9):847-54. PubMed ID: 27160961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucagon-like peptide 1 (GLP-1).
    Müller TD; Finan B; Bloom SR; D'Alessio D; Drucker DJ; Flatt PR; Fritsche A; Gribble F; Grill HJ; Habener JF; Holst JJ; Langhans W; Meier JJ; Nauck MA; Perez-Tilve D; Pocai A; Reimann F; Sandoval DA; Schwartz TW; Seeley RJ; Stemmer K; Tang-Christensen M; Woods SC; DiMarchi RD; Tschöp MH
    Mol Metab; 2019 Dec; 30():72-130. PubMed ID: 31767182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired cardiometabolic responses to glucagon-like peptide 1 in obesity and type 2 diabetes mellitus.
    Moberly SP; Mather KJ; Berwick ZC; Owen MK; Goodwill AG; Casalini ED; Hutchins GD; Green MA; Ng Y; Considine RV; Perry KM; Chisholm RL; Tune JD
    Basic Res Cardiol; 2013 Jul; 108(4):365. PubMed ID: 23764734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucagon-Like Peptide-1 (GLP-1) in the Integration of Neural and Endocrine Responses to Stress.
    Diz-Chaves Y; Herrera-Pérez S; González-Matías LC; Lamas JA; Mallo F
    Nutrients; 2020 Oct; 12(11):. PubMed ID: 33126672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The food intake-suppressive effects of glucagon-like peptide-1 receptor signaling in the ventral tegmental area are mediated by AMPA/kainate receptors.
    Mietlicki-Baase EG; Ortinski PI; Rupprecht LE; Olivos DR; Alhadeff AL; Pierce RC; Hayes MR
    Am J Physiol Endocrinol Metab; 2013 Dec; 305(11):E1367-74. PubMed ID: 24105414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GLP-1 receptor activation modulates appetite- and reward-related brain areas in humans.
    van Bloemendaal L; IJzerman RG; Ten Kulve JS; Barkhof F; Konrad RJ; Drent ML; Veltman DJ; Diamant M
    Diabetes; 2014 Dec; 63(12):4186-96. PubMed ID: 25071023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucagon-like peptide-1 (GLP-1) and the regulation of human invariant natural killer T cells: lessons from obesity, diabetes and psoriasis.
    Hogan AE; Tobin AM; Ahern T; Corrigan MA; Gaoatswe G; Jackson R; O'Reilly V; Lynch L; Doherty DG; Moynagh PN; Kirby B; O'Connell J; O'Shea D
    Diabetologia; 2011 Nov; 54(11):2745-54. PubMed ID: 21744074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of glucagon-like peptide-1 impairment in obesity and potential therapeutic implications.
    Madsbad S
    Diabetes Obes Metab; 2014 Jan; 16(1):9-21. PubMed ID: 23617798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gut hormones as therapeutic agents in treatment of diabetes and obesity.
    Tan T; Bloom S
    Curr Opin Pharmacol; 2013 Dec; 13(6):996-1001. PubMed ID: 24060699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endogenous GLP-1 mediates postprandial reductions in activation in central reward and satiety areas in patients with type 2 diabetes.
    ten Kulve JS; Veltman DJ; van Bloemendaal L; Barkhof F; Deacon CF; Holst JJ; Konrad RJ; Sloan JH; Drent ML; Diamant M; IJzerman RG
    Diabetologia; 2015 Dec; 58(12):2688-98. PubMed ID: 26385462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GLP-1a: Going beyond Traditional Use.
    Laurindo LF; Barbalho SM; Guiguer EL; da Silva Soares de Souza M; de Souza GA; Fidalgo TM; Araújo AC; de Souza Gonzaga HF; de Bortoli Teixeira D; de Oliveira Silva Ullmann T; Sloan KP; Sloan LA
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anorexigenic effects of GLP-1 and its analogues.
    Gallwitz B
    Handb Exp Pharmacol; 2012; (209):185-207. PubMed ID: 22249815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus.
    Vilsbøll T; Krarup T; Sonne J; Madsbad S; Vølund A; Juul AG; Holst JJ
    J Clin Endocrinol Metab; 2003 Jun; 88(6):2706-13. PubMed ID: 12788877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent Advances in Incretin-Based Pharmacotherapies for the Treatment of Obesity and Diabetes.
    Tan Q; Akindehin SE; Orsso CE; Waldner RC; DiMarchi RD; Müller TD; Haqq AM
    Front Endocrinol (Lausanne); 2022; 13():838410. PubMed ID: 35299971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Glucagon-like peptide 1 (GLP-1) analogs in the hippocampus.
    Diz-Chaves Y; Herrera-Pérez S; González-Matías LC; Mallo F
    Vitam Horm; 2022; 118():457-478. PubMed ID: 35180937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Role for GLP-1 in Treating Hyperphagia and Obesity.
    Grill HJ
    Endocrinology; 2020 Aug; 161(8):. PubMed ID: 32516384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of Glucagon-Like Peptide 1 Improvements in Type 2 Diabetes Mellitus and Obesity.
    Nolen-Doerr E; Stockman MC; Rizo I
    Curr Obes Rep; 2019 Sep; 8(3):284-291. PubMed ID: 31124035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.